These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37209394)

  • 1. Purification processes of live virus vaccine candidates expressed in adherent Vero cell lines via multimodal chromatography in flowthrough mode.
    Konstantinidis S; Poplyk MR; Ma WJ; Reilly D; Zhang Y; Wang J; Thompson R; Stiving A; Winters MA; Wang SC; Kristopeit A
    Biotechnol Bioeng; 2024 Aug; 121(8):2482-2499. PubMed ID: 37209394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography.
    Kalbfuss B; Wolff M; Morenweiser R; Reichl U
    Biotechnol Bioeng; 2007 Apr; 96(5):932-44. PubMed ID: 16937411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational development of two flowthrough purification strategies for adenovirus type 5 and retro virus-like particles.
    Nestola P; Peixoto C; Villain L; Alves PM; Carrondo MJ; Mota JP
    J Chromatogr A; 2015 Dec; 1426():91-101. PubMed ID: 26643723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A flow-through chromatography purification process for Vero cell-derived influenza virus (H7N9).
    Fei C; Gao J; Fei C; Ma L; Zhu W; He L; Wu Y; Song S; Li W; Zhou J; Liao G
    J Virol Methods; 2022 Mar; 301():114408. PubMed ID: 34896455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of lentiviral vector stability and development of ion exchange purification processes.
    Ghosh R; Koley S; Gopal S; Rodrigues AL; Dordick JS; Cramer SM
    Biotechnol Prog; 2022 Nov; 38(6):e3286. PubMed ID: 35808852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scalable, integrated downstream process for production of a recombinant measles virus-vectored vaccine.
    Steppert P; Mosor M; Stanek L; Burgstaller D; Palmberger D; Preinsperger S; Pereira Aguilar P; Müllner M; Csar P; Jungbauer A
    Vaccine; 2022 Feb; 40(9):1323-1333. PubMed ID: 35094870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of yellow fever virus produced in Vero cells for inactivated vaccine manufacture.
    Pato TP; Souza MCO; Mattos DA; Caride E; Ferreira DF; Gaspar LP; Freire MS; Castilho LR
    Vaccine; 2019 May; 37(24):3214-3220. PubMed ID: 31047674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Densonucleosis virus purification by ion exchange membranes.
    Specht R; Han B; Wickramasinghe SR; Carlson JO; Czermak P; Wolf A; Reif OW
    Biotechnol Bioeng; 2004 Nov; 88(4):465-73. PubMed ID: 15384051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of cation exchange chromatography in bind and elute and flowthrough mode for the purification of enteroviruses.
    Konstantinidis S; Poplyk MR; Swartz AR; Rustandi RR; Thompson R; Wang SC
    J Chromatogr A; 2022 Aug; 1676():463259. PubMed ID: 35759911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes.
    Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS
    Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of overloaded cation exchange chromatography for monoclonal antibody purification.
    Liu HF; McCooey B; Duarte T; Myers DE; Hudson T; Amanullah A; van Reis R; Kelley BD
    J Chromatogr A; 2011 Sep; 1218(39):6943-52. PubMed ID: 21871630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host cell protein impurities in chromatographic polishing steps for monoclonal antibody purification.
    Levy NE; Valente KN; Lee KH; Lenhoff AM
    Biotechnol Bioeng; 2016 Jun; 113(6):1260-72. PubMed ID: 26550778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings of the 2017 Viral Clearance Symposium, Session 2.2: DSP Unit Operations-Purification Unit Operations.
    Roush D; Kreil TR
    PDA J Pharm Sci Technol; 2018; 72(5):479-487. PubMed ID: 30030354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor.
    Berrie DM; Waters RC; Montoya C; Chatel A; Vela EM
    Vaccine; 2020 Apr; 38(20):3639-3645. PubMed ID: 32247568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single-Step Method for Harvesting Influenza Viral Particles from MDCK Cell Culture Supernatant with High Yield and Effective Impurity Removal.
    Liu S; Li J; Cheng Q; Duan K; Wang Z; Yan S; Tian S; Wang H; Wu S; Lei X; Yang Y; Ma N
    Viruses; 2024 May; 16(5):. PubMed ID: 38793649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo.
    Mundle ST; Hernandez H; Hamberger J; Catalan J; Zhou C; Stegalkina S; Tiffany A; Kleanthous H; Delagrave S; Anderson SF
    PLoS One; 2013; 8(2):e57224. PubMed ID: 23468943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium.
    He C; Yang Z; Tong K
    J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of hydrophobic complex antibody formats using a moderately hydrophobic mixed mode cation exchange resin.
    Koehnlein W; Holzgreve A; Schwendner K; Skudas R; Schelter F
    J Chromatogr A; 2023 Jan; 1687():463696. PubMed ID: 36508767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined screening and in silico strategy for the rapid design of integrated downstream processes for process and product-related impurity removal.
    Vecchiarello N; Timmick SM; Goodwine C; Crowell LE; Love KR; Love JC; Cramer SM
    Biotechnol Bioeng; 2019 Sep; 116(9):2178-2190. PubMed ID: 31081177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.
    Chou AH; Liu CC; Chang CP; Guo MS; Hsieh SY; Yang WH; Chao HJ; Wu CL; Huang JL; Lee MS; Hu AY; Lin SC; Huang YY; Hu MH; Chow YH; Chiang JR; Chang JY; Chong P
    PLoS One; 2012; 7(4):e34834. PubMed ID: 22529942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.